We are conducting routine maintenance on portfolio manager. We'll be back up as soon as possible. Thanks for your patience.

Understanding Factor Models (Part 2)

This is part 2 of a primer on how linear factor models are used to look at fund manager performance.

Samuel Lee 10.07.2014
Facebook Twitter LinkedIn

A version of this article was published in the August 2013 issue of Morningstar ETFInvestor.

In part one of the article, we looked at how to use a single-factor model to examine a fund manager’s performance. In this part of the article, we are using a multifactor model and discuss the use and abuse of factor models.

Multifactor Models
The single-factor model I used to examine Fidelity Magellan's return is a version of the capital asset-pricing model, or CAPM, which predicts that the only way to obtain higher returns is to increase exposure to market beta. One way to test this claim is to sort stocks by beta and see whether higher beta is associated with higher returns. Since the 1960s, researchers have known that it's not.

In the 1970s and 1980s, researchers found that fundamentally cheap stocks beat expensive stocks (value beats growth), and that small-cap stocks beat large-cap stocks (small beats large), even when market exposure is controlled for. Running with these findings, Eugene Fama and Kenneth French augmented CAPM with two factors capturing the excess returns of value and small-cap stocks, producing the now famous Fama-French model.

They constructed their value factor by simulating the return history of a long-short strategy that every year bought low price/book (value) stocks and short-sold high P/B (growth) stocks. Similarly, their size factor was simply the returns from buying small-cap stocks and short-selling large-cap stocks each year.

They didn't add value and size arbitrarily. They found that the lower the P/B or smaller the market cap, the higher a stock's returns were, and this relationship was smooth. On the other hand, beta didn't seem connected to a stock's returns in any meaningful manner. This was, in their eyes, convincing evidence that the stock market "priced" size and value as "risk factors," meaning they were associated with higher returns because they were somehow riskier.

Around the same time Fama and French created their famous namesake model, Narasimhan Jegadeesh and Sheridan Titman found that stocks with relatively high recent returns beat stocks with relatively low returns. Soon, Mark Carhart extended the Fama-French model with a momentum factor, constructed by simulating the returns of a monthly strategy that bought the best-performing stocks by trailing 12-month returns, excluding the most recent month, and short-selling the worst-performing stocks.

The Fama-French-Carhart model has been a mainstay of academic and practitioner research since. It looks like this:

R-Rf = α + β*(Mkt-Rf) + β*HML+ β*SMB + β*UMD,

where R is the return of the asset, Rf is the risk-free rate, α is the unexplained return, Mkt is the U.S. market's return, HML (high-minus-low) is the value-factor-mimicking portfolio's return, SMB (small-minus-big) is the size-factor-mimicking portfolio's return, and UMD (up-minus-down) is the momentum-factor-mimicking portfolio's return. (Technically, each instance of the β term should have a subscript or superscript to denote that they're different, but display limitations prevent us from showing it. There should also be an error term at the end of the equation, but it's omitted for concision.)

This equation simply says that an asset's return above cash can be described as a linear combination of exposures to market, value, size, and momentum factors, plus an unexplained alpha. The β or beta coefficients in front of each term show how sensitive the asset is to each factor, holding all other factors constant.

Notice that the equation looks very much like the simple line equation we countered earlier. That's because they're nearly the same thing, except this time the line is fitted to four different explanatory variables instead of one.

The multiple linear regression procedure attempts to find the alpha and beta coefficient values that best explain the asset's returns.

The table below shows the results of a Carhart regression of Fidelity Magellan's monthly returns. The interpretation is similar to the single-factor regression we looked at earlier. Take HML, the value factor. Its coefficient, or loading, of negative 0.20 means that for each percentage point value stocks beat growth stocks in a month, Magellan's monthly return is predicted to fall by 0.20 percentage points, all other factors held constant. Magellan has a negative loading to the value factor; that is, it's behaved like a growth fund.

Notice that the p-values of the SMB and UMD factors are 0.67 and 0.20, respectively, and the loadings are close to zero. This says that there's a 67% (20%) chance of obtaining as extreme of a value or greater if the true SMB (UMD) loading were zero. By convention a p-value of 5% or lower is considered "statistically significant."

Overall, the results suggest that Magellan had high market beta, a pronounced growth tilt, a large- to mid-cap size tilt, and little exposure to momentum stocks. Unfortunately, it underperformed its regression-based benchmark by 3.85% per year, and this outcome was statistically significant at the 2% level.

The Use and Abuse of Factor Models
Factor models have limitations. First, they often need a lot of historical data to detect statistically significant evidence of skill (or lack thereof). A manager who beats his regression-based benchmark over a decade may still not be deemed to have surpassed the hurdle of statistical significance. Such is the limitation of data. This is why finance researchers often claim that it’s hard to be certain a manager is skilled, even with many years of performance data to consider.

Second, even if you find a strategy with economically and statistically significant alpha, it's unlikely to persist. So you can't run around with a Carhart regression, check every single mutual fund out there, buy the highest-alpha funds, and go on to enjoy outsize returns. In other words, past performance doesn't predict the future (aside from a short-lived "hot hands" effect).

Finally, the factor model can't capture all the important nuances of a strategy or asset. All models are wrong to some degree. The question is whether they say something useful. Fama and French have recently produced some new research suggesting the value factor is really just a combination of two new factors: profitability and investment intensity.

With all those caveats out the way, factor models can be tremendously useful. They can tell you whether an asset or fund is offering something unique--alpha--rather than repackaging known factor exposures that you can obtain with low-cost index funds. Factor models can explicate a managers process and give you more confidence that he's doing what he says he does. And perhaps most importantly, they instill humility in you--beating a factor-based benchmark is often fiendishly difficult.

Summary

  • An asset's periodic returns can be broken down into components attributable to factors, traits that explain or predict returns.
  • Finance researchers broadly agree that stock returns can largely be explained by market, value, size, and momentum factor exposures. (Bond returns can also be broken down into factor exposures, though linear factor models don't work as well with them.)
  • A common way to figure out an asset's factor exposures is to perform a multiple linear regression of an asset's periodic returns (usually monthly) against the returns of long-short factor-mimicking portfolios. Doing so creates a regression-based benchmark that tries to explain the returns of the asset.
  • Unexplainable excess return, or alpha, is often interpreted as evidence of skill or some kind of additional risk not captured by the factor model.
  • Because linear regressions are statistical in nature, their outputs shouldn't be taken as gospel. Even the measures of statistical uncertainty that accompany them, such as the t-stat or p-value, should be taken with a grain of salt.

Facebook Twitter LinkedIn

About Author

Samuel Lee  Samuel Lee is an ETF strategist with Morningstar and editor of Morningstar ETFInvestor

© Copyright 2024 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy          Disclosures